Atherosclerotic Cardiovascular Disease (ASCVD)
Cardiovascular·MeSH: Atherosclerosis
Prevalence
6000.0 / 100K
Incidence
500.0 / 100K/yr
2 drugs in development·1 company·9 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Atherosclerotic Cardiovascular Disease (ASCVD)?
BioSniper tracks 2 drugs in development for Atherosclerotic Cardiovascular Disease (ASCVD) across 1 company.
How many clinical trials target Atherosclerotic Cardiovascular Disease (ASCVD)?
There are 9 clinical trials targeting Atherosclerotic Cardiovascular Disease (ASCVD) tracked by BioSniper.
What is the prevalence of Atherosclerotic Cardiovascular Disease (ASCVD)?
The estimated prevalence of Atherosclerotic Cardiovascular Disease (ASCVD) is approximately 6000.0 per 100,000 population.
Deep-dive into Atherosclerotic Cardiovascular Disease (ASCVD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis